Ajay Royyuru heads the Computational Biology Center at IBM Research, with research groups engaged in various projects at the intersection of life sciences and information technology, including genomics, protein science, systems biology, and bio-nanotechnology.
Working with biologists and institutions around the world, he is engaged in research that will advance personalized, information-based medicine. Ajay led the IBM Research team with National Geographic Society on the Genographic Project. Currently he is leading the research and development of a solution for genomics based personalization of cancer treatment. Ajay has authored numerous researchpublications and several patents in structural and computational biology.
After his bachelors and masters education in human biology and biophysics from All India Institute of Medical Sciences, New Delhi, Ajay obtained his Ph. D. in molecular biology from Tata Institute of Fundamental Research, Mumbai. He had postdoctoral training at Memorial Sloan-Kettering Cancer Center, New York and a brief stint at scientific software development before joining IBM Research.
Ajay is a member of International Society for Computational Biology, IBM Academy of Technology, andIBM Industry Academy.
Who Owns Your Genetic Data?
Salisbury: All right, so we are just going to dive in. My name is Meredith Salisbury. I work with a life science communication company called Bioscribe, and I’m also with Techonomy Bio. It is a pleasure to be here with my fabulous panel, and we’re going to have, what I’m hoping it will be, a […]
Axelrod, De Brouwer, Lee, Royyuru & Tye: The Internet of (Bio)Things
Lee: Hi everyone, thanks so much for joining us today. I’m Stephanie, I’m a reporter at BuzzFeed News, where I cover science, health, and technology. And we’re here today to talk about a really interesting phenomenon that’s happening right now all around us, which is that now, unlike ever before, we can now collect all […]
Conferences
Bio 15
Techonomy Bio is a big-picture exploration of the transformative global social and economic benefits driven by the rapid advances being made in the biological and life sciences.
